These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8218870)

  • 1. Pharmacokinetic model for the absorption of subcutaneously injected soluble insulin and monomeric insulin analogues.
    Trajanoski Z; Wach P; Kotanko P; Ott A; Skraba F
    Biomed Tech (Berl); 1993 Sep; 38(9):224-31. PubMed ID: 8218870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Numerical approximation of mathematical model for absorption of subcutaneously injected insulin.
    Wach P; Trajanoski Z; Kotanko P; Skrabal F
    Med Biol Eng Comput; 1995 Jan; 33(1):18-23. PubMed ID: 7616774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcutaneous insulin absorption explained by insulin's physicochemical properties. Evidence from absorption studies of soluble human insulin and insulin analogues in humans.
    Kang S; Brange J; Burch A; Vølund A; Owens DR
    Diabetes Care; 1991 Nov; 14(11):942-8. PubMed ID: 1797506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant DNA derived monomeric insulin analogue: comparison with soluble human insulin in normal subjects.
    Vora JP; Owens DR; Dolben J; Atiea JA; Dean JD; Kang S; Burch A; Brange J
    BMJ; 1988 Nov; 297(6658):1236-9. PubMed ID: 3145064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absorption kinetics and action profiles of subcutaneously administered insulin analogues (AspB9GluB27, AspB10, AspB28) in healthy subjects.
    Kang S; Brange J; Burch A; Vølund A; Owens DR
    Diabetes Care; 1991 Nov; 14(11):1057-65. PubMed ID: 1797487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incorporating a generic model of subcutaneous insulin absorption into the AIDA v4 diabetes simulator. 3. Early plasma insulin determinations.
    Lehmann ED; Tarín C; Bondia J; Teufel E; Deutsch T
    J Diabetes Sci Technol; 2009 Jan; 3(1):190-201. PubMed ID: 20046665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monomeric insulins and their experimental and clinical implications.
    Brange J; Owens DR; Kang S; Vølund A
    Diabetes Care; 1990 Sep; 13(9):923-54. PubMed ID: 2226110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling absorption kinetics of subcutaneous injected soluble insulin.
    Mosekilde E; Jensen KS; Binder C; Pramming S; Thorsteinsson B
    J Pharmacokinet Biopharm; 1989 Feb; 17(1):67-87. PubMed ID: 2654357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The absorption of subcutaneously injected short-acting soluble insulin: influence of injection technique and concentration.
    Hildebrandt P; Sestoft L; Nielsen SL
    Diabetes Care; 1983; 6(5):459-62. PubMed ID: 6400706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose-insulin regulation model with subcutaneous insulin injection and evaluation using diabetic inpatients data.
    Wu Z; Chui CK; Hong GS; Khoo E; Chang S
    Comput Methods Programs Biomed; 2013 Aug; 111(2):347-56. PubMed ID: 23756090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variability of insulin absorption and insulin action.
    Heinemann L
    Diabetes Technol Ther; 2002; 4(5):673-82. PubMed ID: 12450450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcutaneous absorption of insulin in insulin-dependent diabetic patients. Influence of species, physico-chemical properties of insulin and physiological factors.
    Hildebrandt P
    Dan Med Bull; 1991 Aug; 38(4):337-46. PubMed ID: 1914533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of circulating epinephrine on absorption of subcutaneously injected insulin.
    Fernqvist E; Gunnarsson R; Linde B
    Diabetes; 1988 Jun; 37(6):694-701. PubMed ID: 3289990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetic model of human insulin following different routes of administration.
    Potocka E; Baughman RA; Derendorf H
    J Clin Pharmacol; 2011 Jul; 51(7):1015-24. PubMed ID: 20940337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NovoSol Basal: pharmacokinetics of a novel soluble long acting insulin analogue.
    Jørgensen S; Vaag A; Langkjaer L; Hougaard P; Markussen J
    BMJ; 1989 Aug; 299(6696):415-9. PubMed ID: 2506998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time-action profile of the soluble, fatty acid acylated, long-acting insulin analogue NN304.
    Heinemann L; Sinha K; Weyer C; Loftager M; Hirschberger S; Heise T
    Diabet Med; 1999 Apr; 16(4):332-8. PubMed ID: 10220208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of subcutaneously administered soluble insulin and des-(B26-B30)-insulin-B25-amide in rabbit, pig and healthy man.
    Hartmann H; Moesus E; Creutzfeldt W
    Diabetes Res Clin Pract; 1992 Jun; 16(3):175-81. PubMed ID: 1425137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pharmacokinetics of insulin after continuous subcutaneous infusion or bolus subcutaneous injection in diabetic patients.
    Kobayashi T; Sawano S; Itoh T; Kosaka K; Hirayama H; Kasuya Y
    Diabetes; 1983 Apr; 32(4):331-6. PubMed ID: 6339306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of subcutaneous soluble human insulin and insulin analogues (AspB9, GluB27; AspB10; AspB28) on meal-related plasma glucose excursions in type I diabetic subjects.
    Kang S; Creagh FM; Peters JR; Brange J; Vølund A; Owens DR
    Diabetes Care; 1991 Jul; 14(7):571-7. PubMed ID: 1914797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma insulin profiles after subcutaneous injection: how close can we get to physiology in people with diabetes?
    Home PD
    Diabetes Obes Metab; 2015 Nov; 17(11):1011-20. PubMed ID: 26041603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.